News
Latest news
株式会社aixのプレスリリース(2021年11月11日 13時43分)【戦略的業務提携】空間トランスクリプトマニクス・AI基盤新薬分析企業Portrai社と日本の新薬開発サポート市場進出向け戦略的業務連携へ
Biopsy is one of the most used methods to examine a person’s illness, taking a tissue sample of a patient for analysis. Usually, the samples are thinly s
PortraiTME epitomizes the fusion of AI and medical research in a package designed for ultimate user engagement. The interface elegantly simplifies complex tumor micro-environment analysis, demystifying science without diluting it. The user experience is like a scalpel—precise, effective, and specialized—making intricate medical data accessible and understandable. We marry spatial transcriptomics and deep learning with a human-centered design ethos. In doing so, PortraiTME transcends being just another AI tool; it becomes an essential experience, revolutionizing diagnosis and treatment planning. Experience AI, humanized, with PortraiTME.
Our annual list of the young dreamers, tinkerers, and innovators that are creating technology’s future.
포트래이(Portrai)는 1일 한양대 생체시료 및 다중오믹스 디지털바이오분석지원센터, 첨단바이오융합연구소(HY-ABC)와 각각 공간전사체 분석 파이프라인, 가상실험실 구축을 위한 업무협약(MOU)을 체결했다고 밝혔다.
As the global biomedical industry converges in San Francisco for the 44th Annual J.P. Morgan Healthcare Conference (JPM 2026), South Korea has firmly established itself as a dominant force in the Asia-Pacific biotech landscape. While industry giants like Samsung Biologics and Celltrion commanded attention on the Main Track at the Westin St. Francis, a dynamic wave of innovation was unfolding just blocks away.
As artificial intelligence (AI) continues to revolutionize healthcare, its potential to enhance patient safety and improve radiation protection practices is becoming increasingly evident. This webinar series aims to explore how AI-driven tools and technologies can support and advance the safe and effective use of radiation in medical settings. Tailored for a broad audience of healthcare professionals — including clinicians, radiologists, radiation oncologists, nuclear medicine physicians, technologists, medical physicists, hospital administrators and regulators — each session will feature expert led presentations followed by a live discussion. Participants can deepen their understanding and exchange ideas with leading professionals in the field.
Amgen Korea and the Korea Health Industry Development Institute (KHIDI) on Thursday announced two biotech start-ups — Portrai and BL Melanis — as the winners of the 2025 Golden Ticket, a global open innovation initiative by Amgen to identify promising biotech ventures and support their global growth. 출처 : KBR(https://www.koreabiomed.com)
Celltrion said on the 29th that it signed a joint research agreement with domestic artificial intelligence (AI) new drug developer Portrai to search for new drug targets using spatial transcriptomics and AI technology.
The Korea Startup Forum (KOSFO) announced on July 17 that it successfully held the “KSF IR Day,” a practical IR program supporting promising domestic deep tech startup
At AACR 2024, we explored the poster hall to pick out the posters that would interest the BioTechniques reader and those we found delivered the most interesting or surprising findings. Get our selections below and let us know your thoughts on our Pick of the posters. Contents: pyVIPER: a fast and scalable toolkit for the […]
/PRNewswire/ -- Infortrend® Technology, Inc. (TWSE: 2495), the industry-leading enterprise storage manufacturer, provided South Korean biotech company Portrai...